Ovarian Cancer Institute Inc
- Assets
- $602.0k
- Revenue
- $898.6k
- Investments
- $0.0
- Employees
- 2
- Location
- Atlanta, GA
- Founding
- 12/1999
- Data as of
- 12/2023
- EIN
- 58-2445245
Organization Overview
Ovarian Cancer Institute Inc is located in Atlanta, GA. The organization was established in 1999. According to its NTEE Classification (G30) the organization is classified as: Cancer, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 12/2023, Ovarian Cancer Institute Inc employed 2 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Ovarian Cancer Institute Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Ovarian Cancer Institute Inc generated $898.6k in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 9.5% each year. All expenses for the organization totaled $649.0k during the year ending 12/2023. While expenses have increased by 4.4% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE OVARIAN CANCER INSTITUTE DEVELOPS INNOVATIVE RESEARCH FOR EARLY DETECTION AND MORE EFFECTIVE TREATMENT OF CANCER, PROVIDES EDUCATIONAL OPPORTUNITIES FOR MEDICAL PROFESSIONALS, EDUCATES AND HEIGHTENS AWARENESS OF OVARIAN CANCER SYMPTOMS AND THEIR TREATMENT OPTIONS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE OVARIAN CANCER INSTITUTE CONTINUES SUPPORTING OVARIAN CANCER RESEARCH PROJECTS THAT HAVE SUCCESSFULLY DEVELOPED A BLOOD TEST FOR OVARIAN CANCER THAT HAS NO FALSE POSITIVES (NECESSARY FOR A DISEASE WITH A 1/78 PREVALENCE IN THE POPULATION), AND WHICH IDENTIFIES 98% OF EARLY-STAGE OVARIAN CANCERS AND 89% OF LATE-STAGE OVARIAN CANCERS. THIS TEST WILL SOON BE SUBMITTED FOR FDA APPROVAL. FURTHERMORE, WE HAVE CREATED AI TOOLS THAT CAN OFTEN SUCCESSFULLY PREDICT WHAT DRUGS ARE LIKELY TO BE EFFECTIVE IN A GIVEN PATIENT WITH OVARIAN CANCER, AND ARE DEVELOPING A QUANTITATIVE UNDERSTANDING OF THE NEUROLOGICAL EFFECTS OF ANTICANCER DRUGS. FINALLY, WE ARE DEVELOPING TOOLS THAT CAN IDENTIFY CIRCULATING OVARIAN CANCER TUMOR CELLS, BEFORE THE METASTASES ARE DETECTABLE BY STANDARD APPROACHES.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Kristin Krancer Executive Di | Officer | 40 | $97,467 |
Dana Whitlow Chairperson | Officer | 10 | $0 |
Vicki Barnett COO | Officer | 10 | $0 |
Becca Krumdieck Treasurer | Officer | 10 | $0 |
Marci Knauss Secretary | Officer | 1 | $0 |
Kim Champney Board Member | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $287,549 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $692,610 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $980,159 |
| Total Program Service Revenue | $0 |
| Investment income | $5,762 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | -$87,448 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $898,573 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $365,000 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $97,468 |
| Compensation of current officers, directors, key employees. | $5,068 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $92,462 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $2,000 |
| Payroll taxes | $7,330 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $1,079 |
| Office expenses | $0 |
| Information technology | $7,826 |
| Royalties | $0 |
| Occupancy | $4,055 |
| Travel | $13,284 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $8,239 |
| Interest | $562 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $5,762 |
| All other expenses | $2,696 |
| Total functional expenses | $648,960 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $602,015 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $602,015 |
| Accounts payable and accrued expenses | $4,770 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $4,770 |
| Net assets without donor restrictions | $547,245 |
| Net assets with donor restrictions | $50,000 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $602,015 |